DK1988090T3 - Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf - Google Patents

Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf

Info

Publication number
DK1988090T3
DK1988090T3 DK06775249.3T DK06775249T DK1988090T3 DK 1988090 T3 DK1988090 T3 DK 1988090T3 DK 06775249 T DK06775249 T DK 06775249T DK 1988090 T3 DK1988090 T3 DK 1988090T3
Authority
DK
Denmark
Prior art keywords
imidazole
procedures
preparing
carboxylic acid
acid derivatives
Prior art date
Application number
DK06775249.3T
Other languages
Danish (da)
English (en)
Inventor
Jianhui Guo
Dong An
Original Assignee
Salubris Asset Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salubris Asset Man Co Ltd filed Critical Salubris Asset Man Co Ltd
Application granted granted Critical
Publication of DK1988090T3 publication Critical patent/DK1988090T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK06775249.3T 2006-02-20 2006-07-31 Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf DK1988090T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA2006100239910A CN101024643A (zh) 2006-02-20 2006-02-20 咪唑-5-羧酸类衍生物、制备方法及其应用
PCT/CN2006/001914 WO2007095789A1 (en) 2006-02-20 2006-07-31 Imidazol-5-carboxylic acid derivatives, preparation methods and use therrof

Publications (1)

Publication Number Publication Date
DK1988090T3 true DK1988090T3 (da) 2013-08-05

Family

ID=38436915

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06775249.3T DK1988090T3 (da) 2006-02-20 2006-07-31 Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf

Country Status (12)

Country Link
US (2) USRE44873E1 (enExample)
EP (1) EP1988090B1 (enExample)
JP (1) JP5250760B2 (enExample)
KR (1) KR101179110B1 (enExample)
CN (2) CN101024643A (enExample)
AU (1) AU2006338796B2 (enExample)
CA (1) CA2643005C (enExample)
DK (1) DK1988090T3 (enExample)
ES (1) ES2424154T3 (enExample)
PL (1) PL1988090T3 (enExample)
PT (1) PT1988090E (enExample)
WO (1) WO2007095789A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101024643A (zh) 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑-5-羧酸类衍生物、制备方法及其应用
WO2008067687A1 (en) * 2006-12-06 2008-06-12 Shanghai Allist Pharmaceutical., Inc. The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
CN101214242A (zh) * 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
CN101317842A (zh) * 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101407511B (zh) * 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物
JP2011523941A (ja) * 2008-05-15 2011-08-25 メルク・シャープ・エンド・ドーム・コーポレイション アンギオテンシンii受容体アンタゴニスト
CN101596189A (zh) * 2008-06-05 2009-12-09 上海艾力斯生物医药有限公司 含有咪唑-5-羧酸类衍生物的药用组合物
JP5575783B2 (ja) * 2008-12-12 2014-08-20 ファーマコステック カンパニー リミテッド トリフェニルメタン保護基の除去方法
KR101213467B1 (ko) * 2010-04-30 2012-12-20 진양제약주식회사 로자탄 대사체 이엑스피-3174 이수화물의 신규한 제조 방법
CN103012377A (zh) * 2011-09-27 2013-04-03 江苏艾力斯生物医药有限公司 一种咪唑-5-羧酸酯的重结晶方法
CN102558064B (zh) * 2012-01-29 2014-04-16 安润医药科技(苏州)有限公司 抗高血压化合物及其制备方法和应用,以及其在药学上可接受的盐
CN104610232B (zh) * 2013-11-01 2019-09-20 深圳信立泰药业股份有限公司 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物
CN103965171A (zh) * 2014-04-30 2014-08-06 上海艾力斯医药科技有限公司 一种阿利沙坦酯的制备方法
CN106188012B (zh) * 2014-06-20 2018-11-30 深圳信立泰药业股份有限公司 一种阿利沙坦酯结晶及其制备方法及含有该结晶的药物组合物
CN105218527B (zh) * 2015-10-10 2018-04-24 江苏宝众宝达药业有限公司 一种exp-3174的制备方法
US11026925B2 (en) 2016-01-20 2021-06-08 Shenzhen Salubris Pharmaceuticals Co. Ltd. Angiotensin II receptor antagonist metabolite and NEP inhibitor composite and preparation method thereof
CN119371408B (zh) * 2024-12-27 2025-04-22 安徽艾立德制药有限公司 一种无定形的阿利沙坦酯及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5196444A (en) 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
AT398202B (de) * 1991-10-04 1994-10-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
ES2155827T3 (es) * 1992-06-02 2001-06-01 Sankyo Co 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico.
JPH083162A (ja) * 1994-04-19 1996-01-09 Tanabe Seiyaku Co Ltd イミダゾピリジン誘導体及びその製法
ES2167571T3 (es) * 1995-06-07 2002-05-16 Searle & Co Terapia de combinacion de antagonista de aldosterona epoxi-esteroideo y antagonista de angiotensina ii para el tratamiento del fallo cardiaco congestivo.
KR20060056352A (ko) 2003-07-31 2006-05-24 니콕스 에스. 에이. 안지오텐신ⅱ 수용체 차단제 유도체들
US20070238740A1 (en) 2003-08-28 2007-10-11 Nitromed, Inc. Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
DE602006010364D1 (de) 2005-04-22 2009-12-24 Daiichi Sankyo Co Ltd Pharmazeutikum zur prävention oder behandlung von metabolischer knochenkrankheit
CN101024643A (zh) 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑-5-羧酸类衍生物、制备方法及其应用
WO2008067687A1 (en) 2006-12-06 2008-06-12 Shanghai Allist Pharmaceutical., Inc. The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
CN101214242A (zh) 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
CN101317842A (zh) 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101407511B (zh) 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物

Also Published As

Publication number Publication date
USRE44873E1 (en) 2014-04-29
CN101031562A (zh) 2007-09-05
ES2424154T3 (es) 2013-09-27
EP1988090A4 (en) 2010-06-30
US20090036505A1 (en) 2009-02-05
JP5250760B2 (ja) 2013-07-31
KR20080096707A (ko) 2008-10-31
EP1988090B1 (en) 2013-05-01
JP2009527509A (ja) 2009-07-30
WO2007095789A1 (en) 2007-08-30
EP1988090A1 (en) 2008-11-05
KR101179110B1 (ko) 2012-09-07
AU2006338796B2 (en) 2011-05-12
CN100506818C (zh) 2009-07-01
CA2643005C (en) 2012-05-15
CA2643005A1 (en) 2007-08-30
PL1988090T3 (pl) 2013-10-31
CN101024643A (zh) 2007-08-29
PT1988090E (pt) 2013-08-05
AU2006338796A1 (en) 2007-08-30
US7858651B2 (en) 2010-12-28

Similar Documents

Publication Publication Date Title
DK2209375T3 (da) Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
DK2010501T3 (da) Imidazolbaserede forbindelser, sammensætninger omfattende disse og fremgangsmåder for deres anvendelse
DK3461503T3 (da) Fremgangsmåder til indgivelse af tetrahydrobiopterin, associerede sammensætninger og målingsfremgangsmåder
IS8770A (is) Plástrar, kerfi og aðferðir fyrir ei-ífarandi glúkósa mælingu
DK3067064T3 (da) Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf
DK2069352T3 (da) Bestemte kemiske enheder, sammensætninger og fremgangsmåder
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
FR2899308B1 (fr) Raccord rapide.
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
DK2147315T3 (da) Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf
DK3851447T3 (da) Fremgangsmåder, forbindelser, sammensætninger og vehikler til administration af 3-amino-1-propansulfonsyre
EP2033181A4 (en) POSITIONING SYSTEM OF A CONTROL DISPLAY
DK2044002T3 (da) Fremgangsmåde til fremstilling af 3-substituerede 2-amino-5-halobenzamider
DE502007000819D1 (de) Abgasnachbehandlungssystem
DK2139987T5 (da) Fremgangsmåder til proteinfremstilling med anti-senescens-forbindelser
DK2120591T3 (da) Ny drikkeyoghurt og fremgangsmåde til fremstilling deraf
DE502007005327D1 (de) Abgasnachbehandlungssystem
DK2231614T3 (da) Quinolinderivativer og anvendelse af disse som fungicider
DE502007000724D1 (de) Abgasnachbehandlungssystem
DK2057153T3 (da) (3-aryl-piperazin-1-yl)-derivater af 6,7 dialkoxyquinazolin, 6,7- dialkoxyphtalazin og 6,7-dialkoxyisoquinolin
DK2134663T3 (da) Beskyttelseslag på højtemperaturudholdende chromoxiddannende substrater, og fremgangsmåde til fremstilling deraf
DK1988090T3 (da) Imidazol-5-carboxylsyrederivater, fremgangsmåder til fremstilling af disse og anvendelse deraf
DE502006002276D1 (de) Integriertes medizinisches Trackingsystem
DK2201020T3 (da) Fremgangsmåde til fremstilling af 2' -deoxy-5-azacytidin (decitabin)
DK2158201T3 (da) Derivater af 7-alkynyl-1,8-naphthyridon, fremgangsmåde til fremstilling deraf og anvendelse deraf i terapi